Immune Function in Systemic Lupus Erythematosus. Impairment of in Vitro T-cell Proliferation and in Vivo Antibody Response to Exogenous Antigen

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1979 May 1

PMID 312809

Citations 27

Authors

A B Gottlieb

R G Lahita

N Chiorazzi

H G KUNKEL

Affiliations

Soon will be listed here.

Abstract

Peripheral blood mononuclear cells from 46 systemic lupus erythematosus (SLE) patients showed reduced ability to proliferate in vitro in response to the soluble antigen, tetanus toxoid, as compared with 96 normal controls. Special studies of 27 untreated SLE patients also revealed significantly decreased blastogenic responses to tetanus toxoid. In both the total and untreated SLE populations, decreased mean tetanus antibody titers also were found as compared with the control population. However, the reduction in antibody titer and blastogenic response was not strictly parallel. A limited immunization program was initiated in low-responding volunteers from the SLE and normal populations. Three out of four SLE patients did not develop a significant blastogenic response despite increases in anti-tetanus titers after immunization, whereas all normals showed significant increases in both blastogenic and antibody responses. The accumulated evidence indicated that the unresponsiveness was the result of a defect in T-cell function. Monocyte reactivity was demonstrated to be normal, and no evidence was found for the presence of suppressor cells, inhibition by immune complexes, or increased prostaglandins to explain the defect.

Citing Articles

Regulatory T cell-deficient scurfy mice develop systemic autoimmune features resembling lupus-like disease.

Hadaschik E, Wei X, Leiss H, Heckmann B, Niederreiter B, Steiner G Arthritis Res Ther. 2015; 17:35.

PMID: 25890083 PMC: 4391674. DOI: 10.1186/s13075-015-0538-0.

Herpes Zoster Infections in SLE in a University Hospital in Saudi Arabia: Risk Factors and Outcomes.

Sayeeda A, Al Arfaj H, Khalil N, Al Arfaj A Autoimmune Dis. 2010; 2011:174891.

PMID: 21152215 PMC: 2989732. DOI: 10.4061/2010/174891.

The imbalance between regulatory and IL-17-secreting CD4+ T cells in lupus patients.

Ma J, Yu J, Tao X, Cai L, Wang J, Zheng S Clin Rheumatol. 2010; 29(11):1251-8.

PMID: 20563617 DOI: 10.1007/s10067-010-1510-7.

Pathogenesis of human systemic lupus erythematosus: recent advances.

Crispin J, Liossis S, Kis-Toth K, Lieberman L, Kyttaris V, Juang Y Trends Mol Med. 2010; 16(2):47-57.

PMID: 20138006 PMC: 2823952. DOI: 10.1016/j.molmed.2009.12.005.

Defective in vitro IL-2 production in lupus is an early but secondary event paralleling disease activity: evidence from the murine parent-into-F1 model supports staging of IL-2 defects in human lupus.

Via C, Shearer G Autoimmunity. 2009; 43(1):23-31.

PMID: 20001649 PMC: 3215295. DOI: 10.3109/08916930903374808.

References

ZINGALE S, SANCHEZAVALOS J, Andrada J, STRINGA S, Manni J . APPEARANCE OF ANTICOAGULANT FACTORS AND CERTAIN "AUTOIMMUNE" ANTIBODIES FOLLOWING ANTIGENIC STIMULATION WITH BLOOD GROUP SUBSTANCES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS. Arthritis Rheum. 1963; 6:581-98. DOI: 10.1002/art.1780060503. View

MUSCHEL L . Systemic lupus erythematosus and normal antibodies. Proc Soc Exp Biol Med. 1961; 106:622-5. DOI: 10.3181/00379727-106-26422. View

Goodwin J, Messner R, Bankhurst A, Peake G, Saiki J, Williams Jr R . Prostaglandin-producing suppressor cells in Hodgkin's disease. N Engl J Med. 1977; 297(18):963-8. DOI: 10.1056/NEJM197711032971802. View

Yano A, Schwartz R, Paul W . Antigen presentation in the murine T-lymphocyte proliferative response. I. Requirement for genetic identity at the major histocompatibility complex. J Exp Med. 1977; 146(3):828-43. PMC: 2180782. DOI: 10.1084/jem.146.3.828. View

Arend W, Emmerich T, Sturge J, Starkebaum G . Monocyte-reactive antibodies in patients with systemic lupus erythematosus. Arthritis Rheum. 1977; 20(5):1049-57. DOI: 10.1002/art.1780200503. View

Evans R, Faldetta T, Humphreys R, Pratt D, Yunis E, Schlossman S . Peripheral human T cells sensitized in mixed leukocyte culture synthesize and express Ia-like antigens. J Exp Med. 1978; 148(5):1440-5. PMC: 2185039. DOI: 10.1084/jem.148.5.1440. View

Chiorazzi N, Fu S, Montazeri G, KUNKEL H, Rai K, Gee T . T cell helper defect in patients with chronic lymphocytic leukemia. J Immunol. 1979; 122(3):1087-90. View

Mudawwar F, Yunis E, Geha R . Antigen-specific helper factor in man. J Exp Med. 1978; 148(4):1032-43. PMC: 2185019. DOI: 10.1084/jem.148.4.1032. View

Williams G, Steinberg A, Reinertsen J, Klassen L, Decker J, Dolin R . Influenza immunization in systemic lupus eruthematosus. A double-blind trial. Ann Intern Med. 1978; 88(6):729-34. DOI: 10.7326/0003-4819-88-6-729. View

10.

Moretta L, Ferrarini M, Cooper M . Characterization of human T-cell subpopulations as defined by specific receptors for immunoglobulins. Contemp Top Immunobiol. 1978; 8:19-53. DOI: 10.1007/978-1-4684-0922-2_2. View

11.

LING N, Bishop S, Jefferis . Use of antibody-coated red cells for the sensitive detection of antigen and in rosette tests for cells bearing surface immunoglobulins. J Immunol Methods. 1977; 15(3):279-89. DOI: 10.1016/0022-1759(77)90065-5. View

12.

Fu S, Chiorazzi N, Wang C, Montrazeri G, KUNKEL H, Ko H . Ia-bearing T lymphocytes in man. Their identification and role in the generation of allogeneic helper activity. J Exp Med. 1978; 148(5):1423-8. PMC: 2185058. DOI: 10.1084/jem.148.5.1423. View

13.

Faith R, Luster M, Moore J . Chemical separation of helper cell function and delayed hypersensitivity responses. Cell Immunol. 1978; 40(2):275-84. DOI: 10.1016/0008-8749(78)90335-0. View

14.

Louie J, Nies K, Shoji K, Fraback R, Abrass C, Border W . Clinical and antibody responses after influenza immunization in systemic lupus erythematosus. Ann Intern Med. 1978; 88(6):790-2. DOI: 10.7326/0003-4819-88-6-790. View

15.

Brodman R, GILFILLAN R, Glass D, Schur P . Influenzal vaccine response in systemic lupus erythematosus. Ann Intern Med. 1978; 88(6):735-40. DOI: 10.7326/0003-4819-88-6-735. View

16.

Horowitz S, Borcherding W, Moorthy A, Chesney R, Hong R . Induction of suppressor T cells in systemic lupus erythematosus by thymosin and cultured thymic epithelium. Science. 1977; 197(4307):999-1001. DOI: 10.1126/science.302032. View

17.

Ristow S, DOUGLAS Jr R, CONDEMI J . Influenza vaccination of patients with systemic lupus erythematosus. Ann Intern Med. 1978; 88(6):786-9. DOI: 10.7326/0003-4819-88-6-786. View

18.

Andrianakos A, Tsichlis P, Merikas E, Marketos S, Sharp J, Merikas G . Cell-mediated immunity in systemic lupus erythematosus. Clin Exp Immunol. 1977; 30(1):89-96. PMC: 1541176. View

19.

Johnson Jr W, Mei B, COHN Z . The separation, long-term cultivation, and maturation of the human monocyte. J Exp Med. 1977; 146(6):1613-26. PMC: 2181917. DOI: 10.1084/jem.146.6.1613. View

20.

Horwitz D, Garrett M, Craig A . Serum effects of mitogenic reactivity in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma. Technical considerations and lack of correlation with anti-lymphocyte antibodies. Clin Exp Immunol. 1977; 27(1):100-10. PMC: 1540902. View